UniProt ID | UBAC1_HUMAN | |
---|---|---|
UniProt AC | Q9BSL1 | |
Protein Name | Ubiquitin-associated domain-containing protein 1 | |
Gene Name | UBAC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 405 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Non-catalytic subunit of the KPC complex that acts as E3 ubiquitin-protein ligase. Required for poly-ubiquitination and proteasome-mediated degradation of CDKN1B during G1 phase of the cell cycle.. | |
Protein Sequence | MFVQEEKIFAGKVLRLHICASDGAEWLEEATEDTSVEKLKERCLKHCAHGSLEDPKSITHHKLIHAASERVLSDARTILEENIQDQDVLLLIKKRAPSPLPKMADVSAEEKKKQDQKAPDKEAILRATANLPSYNMDRAAVQTNMRDFQTELRKILVSLIEVAQKLLALNPDAVELFKKANAMLDEDEDERVDEAALRQLTEMGFPENRATKALQLNHMSVPQAMEWLIEHAEDPTIDTPLPGQAPPEAEGATAAASEAAAGASATDEEARDELTEIFKKIRRKREFRADARAVISLMEMGFDEKEVIDALRVNNNQQNAACEWLLGDRKPSPEELDKGIDPDSPLFQAILDNPVVQLGLTNPKTLLAFEDMLENPLNSTQWMNDPETGPVMLQISRIFQTLNRT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MFVQEEKI -------CCCCCHHH | 7.19 | 22814378 | |
7 | Ubiquitination | -MFVQEEKIFAGKVL -CCCCCHHHHCCCEE | 42.23 | 21890473 | |
12 | Ubiquitination | EEKIFAGKVLRLHIC CHHHHCCCEEEEEEE | 34.37 | - | |
45 | Ubiquitination | KLKERCLKHCAHGSL HHHHHHHHHCCCCCC | 40.02 | - | |
56 | Ubiquitination | HGSLEDPKSITHHKL CCCCCCCCCCCHHHH | 67.80 | - | |
62 | Ubiquitination | PKSITHHKLIHAASE CCCCCHHHHHHHHHH | 41.34 | - | |
68 | Phosphorylation | HKLIHAASERVLSDA HHHHHHHHHHHHHHH | 27.07 | 23312004 | |
93 | Ubiquitination | QDVLLLIKKRAPSPL CCEEEEEECCCCCCC | 35.86 | - | |
98 | Phosphorylation | LIKKRAPSPLPKMAD EEECCCCCCCCCCCC | 37.78 | 25159151 | |
107 | Phosphorylation | LPKMADVSAEEKKKQ CCCCCCCCHHHHHHH | 30.43 | 26074081 | |
111 | Ubiquitination | ADVSAEEKKKQDQKA CCCCHHHHHHHHCCC | 57.69 | 21890473 | |
112 | Ubiquitination | DVSAEEKKKQDQKAP CCCHHHHHHHHCCCC | 59.97 | - | |
117 | Ubiquitination | EKKKQDQKAPDKEAI HHHHHHCCCCCHHHH | 70.90 | - | |
121 | Ubiquitination | QDQKAPDKEAILRAT HHCCCCCHHHHHHHH | 48.24 | 21890473 | |
154 | Ubiquitination | DFQTELRKILVSLIE HHHHHHHHHHHHHHH | 53.68 | 21890473 | |
178 | Ubiquitination | PDAVELFKKANAMLD HHHHHHHHHHHHCCC | 64.70 | 21890473 | |
178 | Acetylation | PDAVELFKKANAMLD HHHHHHHHHHHHCCC | 64.70 | 24627041 | |
179 | Ubiquitination | DAVELFKKANAMLDE HHHHHHHHHHHCCCC | 39.27 | 21890473 | |
279 | Ubiquitination | DELTEIFKKIRRKRE HHHHHHHHHHHHHHH | 53.61 | - | |
296 | Phosphorylation | ADARAVISLMEMGFD HHHHHHHHHHHCCCC | 18.31 | 22210691 | |
305 | Ubiquitination | MEMGFDEKEVIDALR HHCCCCHHHHHHHHH | 60.16 | - | |
330 | Ubiquitination | EWLLGDRKPSPEELD HHHHCCCCCCHHHHH | 55.37 | 21890473 | |
332 | Phosphorylation | LLGDRKPSPEELDKG HHCCCCCCHHHHHCC | 48.23 | 26657352 | |
338 | Ubiquitination | PSPEELDKGIDPDSP CCHHHHHCCCCCCCH | 71.09 | - | |
344 | Phosphorylation | DKGIDPDSPLFQAIL HCCCCCCCHHHHHHH | 28.96 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBAC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBAC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CPSF6_HUMAN | CPSF6 | physical | 16189514 | |
RN123_HUMAN | RNF123 | physical | 17353931 | |
IQGA2_HUMAN | IQGAP2 | physical | 17353931 | |
MYH2_HUMAN | MYH2 | physical | 17353931 | |
RN123_HUMAN | RNF123 | physical | 16227581 | |
PSMD4_HUMAN | PSMD4 | physical | 16227581 | |
PSMD7_HUMAN | PSMD7 | physical | 16227581 | |
PSMD6_HUMAN | PSMD6 | physical | 16227581 | |
RN123_HUMAN | RNF123 | physical | 15746103 | |
A4_HUMAN | APP | physical | 21832049 | |
UTP6_HUMAN | UTP6 | physical | 22939629 | |
VPS25_HUMAN | VPS25 | physical | 22939629 | |
UBP7_HUMAN | USP7 | physical | 22939629 | |
TRIM2_HUMAN | TRIM2 | physical | 25416956 | |
TRI39_HUMAN | TRIM39 | physical | 25416956 | |
DVL2_HUMAN | DVL2 | physical | 21516116 | |
TRIM2_HUMAN | TRIM2 | physical | 21516116 | |
RS27A_HUMAN | RPS27A | physical | 28514442 | |
RN123_HUMAN | RNF123 | physical | 28514442 | |
UBB_HUMAN | UBB | physical | 28514442 | |
BAP31_HUMAN | BCAP31 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, AND MASSSPECTROMETRY. |